Weijin Huang to Humans
This is a "connection" page, showing publications Weijin Huang has written about Humans.
Connection Strength
0.072
-
The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom. Front Immunol. 2021; 12:687869.
Score: 0.008
-
Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination. Emerg Microbes Infect. 2021 Dec; 10(1):1390-1403.
Score: 0.002
-
Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants. Emerg Microbes Infect. 2021 Dec; 10(1):1519-1529.
Score: 0.002
-
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19. Emerg Microbes Infect. 2021 Dec; 10(1):1574-1588.
Score: 0.002
-
Polyketone metabolites isolated from Rhodiola tibetica endohytic fungus Alternaria sp. HJT-Y7 and their SARS-CoV-2 virus inhibitory activitives. Bioorg Chem. 2021 11; 116:105309.
Score: 0.002
-
Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants. Cell Res. 2021 10; 31(10):1130-1133.
Score: 0.002
-
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants. Nat Commun. 2021 08 17; 12(1):5000.
Score: 0.002
-
Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage. Bioorg Chem. 2021 10; 115:105196.
Score: 0.002
-
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nat Commun. 2021 07 09; 12(1):4210.
Score: 0.002
-
The molecular basis for SARS-CoV-2 binding to dog ACE2. Nat Commun. 2021 07 07; 12(1):4195.
Score: 0.002
-
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines. Cell Res. 2021 07; 31(7):732-741.
Score: 0.002
-
The first Chinese national standards for SARS-CoV-2 neutralizing antibody. Vaccine. 2021 06 23; 39(28):3724-3730.
Score: 0.002
-
Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants. Signal Transduct Target Ther. 2021 05 17; 6(1):196.
Score: 0.002
-
Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials. Chin Med J (Engl). 2021 Apr 28; 134(11):1289-1298.
Score: 0.002
-
Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Signal Transduct Target Ther. 2021 03 27; 6(1):134.
Score: 0.002
-
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates. Nat Commun. 2021 03 01; 12(1):1346.
Score: 0.002
-
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021 04 29; 184(9):2362-2371.e9.
Score: 0.002
-
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect. 2020 Dec; 9(1):680-686.
Score: 0.002
-
Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals. Nat Microbiol. 2021 01; 6(1):51-58.
Score: 0.002
-
Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys. Nat Commun. 2020 11 13; 11(1):5752.
Score: 0.002
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 01; 21(1):39-51.
Score: 0.002
-
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection. Front Med. 2020 Dec; 14(6):746-751.
Score: 0.002
-
Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat Protoc. 2020 11; 15(11):3699-3715.
Score: 0.002
-
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020 10; 586(7830):572-577.
Score: 0.002
-
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science. 2020 09 18; 369(6510):1505-1509.
Score: 0.002
-
A Thermostable mRNA Vaccine against COVID-19. Cell. 2020 09 03; 182(5):1271-1283.e16.
Score: 0.002
-
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell. 2020 09 03; 182(5):1284-1294.e9.
Score: 0.002
-
High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients. J Infect. 2020 09; 81(3):420-426.
Score: 0.002
-
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020 08; 584(7819):120-124.
Score: 0.002
-
Absence of hepatitis E virus RNA in semen samples of infertile male in China. Gut. 2020 07; 69(7):1363-1364.
Score: 0.002
-
Antigenic Drift of Influenza A(H7N9) Virus Hemagglutinin. J Infect Dis. 2019 01 01; 219(1):19-25.
Score: 0.002
-
Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities. Emerg Microbes Infect. 2019; 8(1):272-281.
Score: 0.002
-
Hepatitis E virus was not detected in feces and milk of cows in Hebei province of China: No evidence for HEV prevalence in cows. Int J Food Microbiol. 2019 Feb 16; 291:5-9.
Score: 0.002
-
A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV. Viruses. 2018 08 23; 10(9).
Score: 0.002
-
Current status on the development of pseudoviruses for enveloped viruses. Rev Med Virol. 2018 01; 28(1).
Score: 0.001
-
Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells. Hum Vaccin Immunother. 2018 01 02; 14(1):199-208.
Score: 0.001
-
Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection. Sci Rep. 2017 03 30; 7:45552.
Score: 0.001